Managed Care - July 2008 - (Page H21) CONTINUING EDUCATION POST-TEST Hematologic Cancer as a Chronic Disease Please tear out the assessment/evaluation form on page 20. On the answer sheet, place an X through the box of the letter corresponding to the correct response for each question. There is only ONE correct answer to each question. 1. The two most significant risk factors for myelodysplastic syndromes (MDS) are: a. Age and smoking. b. Fanconi’s anemia and prior drug use. c. Radiation exposure and smoking. d. Prior treatment of cancer and a patient’s age. 2. Which of the following is NOT a pathophysiological feature of MDS: a. Hematopoietic stem cells’ failure to differentiate properly. b. Bone marrow populated with dysplastic cells. c. An increase in apoptosis that occurs among healthy cells in the bone marrow. d. Hematopoietic stem cells dramatically decrease in number. 3. The most common cytopenia found among patients with MDS is: a. Neutropenia. b. Thrombocytopenia. c. Anemia. d. Leukocytopenia. 4. Treatment with erythropoietin (EPO) is most effective in patients whose serum EPO level is: a. Below 500 mU/mL. b. Between 450 and 550 mU/mL. c. Above 500 mU/mL. d. Between 475 and 575 mU/mL. 5. Lytic bone lesions occur in which percentage of patients with myeloma? a. 20. b. 80. c. 70. d. 40. 6. According to the National Comprehensive Cancer Network, patients with asymptomatic myeloma do not require treatment, but should be observed every: a. 3 to 6 years. b. 9 to 12 months. c. 1 to 2 years. d. 3 to 6 months. 7. In 2007, the New England Journal of Medicine published two large trials regarding the use of for the treatment of patients with relapsed/refractory myeloma: a. Melphalan. b. Thalidomide. c. Bortezomib. d. Lenalidomide. 8. According to changes that have occurred in Medicare, which of the following vaccines falls under Part B coverage if it is given as a result of an acute injury to the patient? a. Tetanus. b. Influenza. c. Pneumococcal. d. Hepatitis B. 9. When examining protected classes of medicine under Medicare Part D, which of the following groups is NOT included? a. HIV/AIDS mediations. b. Anticonvulsants. c. Immunosuppressants. d. Nonsteroidal anti-inflammatory agents. 10. When a patient hits the catastrophic coverage threshold, what share of the cost of their medications do they become responsible for? a. 1 percent. b. 5 percent. c. 10 percent. d. 15 percent. SUPPLEMENT / HEMATOLOGIC CANCER 21
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.